BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10639471)

  • 1. Phagocytosed Bordetella pertussis fails to survive in human neutrophils.
    Lenz DH; Weingart CL; Weiss AA
    Infect Immun; 2000 Feb; 68(2):956-9. PubMed ID: 10639471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils.
    Weingart CL; Broitman-Maduro G; Dean G; Newman S; Peppler M; Weiss AA
    Infect Immun; 1999 Aug; 67(8):4264-7. PubMed ID: 10417202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
    Weingart CL; Mobberley-Schuman PS; Hewlett EL; Gray MC; Weiss AA
    Infect Immun; 2000 Dec; 68(12):7152-5. PubMed ID: 11083845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.
    Schaeffer LM; Weiss AA
    Infect Immun; 2001 Dec; 69(12):7635-41. PubMed ID: 11705943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.
    Mobberley-Schuman PS; Weiss AA
    Infect Immun; 2005 Nov; 73(11):7317-23. PubMed ID: 16239529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils.
    Lamberti Y; Perez Vidakovics ML; van der Pol LW; Rodríguez ME
    Microb Pathog; 2008 Jun; 44(6):501-11. PubMed ID: 18276103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.
    Weingart CL; Weiss AA
    Infect Immun; 2000 Mar; 68(3):1735-9. PubMed ID: 10679000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc receptor-mediated immunity against Bordetella pertussis.
    Rodriguez ME; Hellwig SM; Hozbor DF; Leusen J; van der Pol WL; van de Winkel JG
    J Immunol; 2001 Dec; 167(11):6545-51. PubMed ID: 11714823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of Bordetella pertussis incubated with convalescent serum.
    Mobberley-Schuman PS; Connelly B; Weiss AA
    J Infect Dis; 2003 May; 187(10):1646-53. PubMed ID: 12721945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.
    Steed LL; Setareh M; Friedman RL
    J Leukoc Biol; 1991 Oct; 50(4):321-30. PubMed ID: 1919361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes.
    Hazenbos WL; van den Berg BM; van't Wout JW; Mooi FR; van Furth R
    Infect Immun; 1994 Nov; 62(11):4818-24. PubMed ID: 7927760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression.
    Fedele G; Stefanelli P; Spensieri F; Fazio C; Mastrantonio P; Ausiello CM
    Infect Immun; 2005 Mar; 73(3):1590-7. PubMed ID: 15731058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis.
    Hellwig SM; van Oirschot HF; Hazenbos WL; van Spriel AB; Mooi FR; van De Winkel JG
    J Infect Dis; 2001 Mar; 183(6):871-9. PubMed ID: 11237803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and simple method for evaluation of serum opsonic capacity against Bordetella pertussis by chemiluminescence.
    Lilius EM; Mertsola J; Leivo P; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():373-7. PubMed ID: 2872125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antibiotics and antibody on phagocytic bactericidal activity of polymorphonuclear neutrophils of Bordetella pertussis].
    Muraoka H; Aoyama T; Saika T; Sato Y; Kobayashi I; Akita H; Iwata S; Sato Y; Sunakawa K
    Kansenshogaku Zasshi; 1999 Mar; 73(3):239-43. PubMed ID: 10222670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human neutrophil type 3 complement receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli.
    Gordon DL; Rice JL; McDonald PJ
    Immunology; 1989 Aug; 67(4):460-5. PubMed ID: 2527804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immune sera in the in-vitro phagocytosis of Bordetella pertussis strains.
    Stefanelli P; Ippoliti R; Fazio C; Mastrantonio P
    Microb Pathog; 2002 Mar; 32(3):135-41. PubMed ID: 11855944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.
    Kirimanjeswara GS; Agosto LM; Kennett MJ; Bjornstad ON; Harvill ET
    J Clin Invest; 2005 Dec; 115(12):3594-601. PubMed ID: 16294220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The respiratory burst response to Histoplasma capsulatum by human neutrophils. Evidence for intracellular trapping of superoxide anion.
    Schnur RA; Newman SL
    J Immunol; 1990 Jun; 144(12):4765-72. PubMed ID: 1972167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro.
    Cundell DR; Kanthakumar K; Taylor GW; Goldman WE; Flak T; Cole PJ; Wilson R
    Infect Immun; 1994 Feb; 62(2):639-43. PubMed ID: 8300220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.